发明申请
- 专利标题： ANTIBODIES CAPABLE OF BINDING TO THE COAGULATION FACTOR XIA AND USES THEREOF
-
申请号： US16292196申请日： 2019-03-04
-
公开(公告)号： US20190284300A1公开(公告)日： 2019-09-19
- 发明人: Andreas WILMEN , Julia STRAßBURGER , Frank DITTMER , Michael STRERATH , Anja BUCHMÜLLER , Joanna GRUDZINSKA-GOEBEL , Ricarda FINNERN , Martina SCHÄFER , Christoph GERDES , Hannah JÖRIßEN , Asako ITAKURA , Philberta Y. LEUNG , Erik TUCKER
- 申请人： Bayer Pharma Aktiengesellschaft
- 申请人地址： DE Berlin
- 专利权人： Bayer Pharma Aktiengesellschaft
- 当前专利权人： Bayer Pharma Aktiengesellschaft
- 当前专利权人地址： DE Berlin
- 优先权： EP12167438.6 20120510; EP12181697.9 20120824; EP13150361.7 20130107
- 主分类号： C07K16/36
- IPC分类号： C07K16/36
摘要：
The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.
公开/授权文献
信息查询
